Literature DB >> 26449772

Instruments for assessment of impairments and activity limitations in patients with hand conditions: A European Delphi study.

Lucelle A W van de Ven-Stevens1, Maud J L Graff, Ruud W Selles, Ton A R Schreuders, Harmen van der Linde, Paul H Spauwen, Alexander C H Geurts.   

Abstract

OBJECTIVE: To reach multidisciplinary European consensus on the assessment tools for impairments and activity limitations in patients with hand conditions.
DESIGN: Electronic Delphi method.
SUBJECTS: Thirty experts from European societies for hand therapy, hand surgery, and physical and rehabilitation medicine.
METHODS: In 3 rounds, participants were asked which of 13 preselected categories of the Brief International Classification of Functioning, Disability and Health (ICF) Core Set for Hand Conditions should be assessed. In addition, they were asked to choose which of 55 preselected instruments they preferred for each category by confirming or rejecting instrument-specific statements.
RESULTS: All 13 preselected ICF categories were considered relevant. Consensus was based on ≥ 75% agreement. After 3 rounds, 9 instruments were selected: Shape Texture Identification Test, Semmes Weinstein Monofilament Test, Visual Analogue Scale for pain, goniometer, Jamar Dynamometer, Pinch Gauge Device, Cold Intolerance Symptom Severity questionnaire, Canadian Occupational Performance Measure, and Disabilities of the Arm, Shoulder and Hand Questionnaire. It remained undecided whether to use the Nine-Hole Pegboard Test or the Purdue Pegboard Test.
CONCLUSION: In this European Delphi study, multidisciplinary consensus was reached on 9 assessment tools for impairments and activity limitations in patients with hand conditions addressing 13 categories of the Brief ICF Core Set for Hand Conditions.

Entities:  

Mesh:

Year:  2015        PMID: 26449772     DOI: 10.2340/16501977-2015

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  7 in total

1.  Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act.

Authors:  Thomas Lutz; Anette Lampert; Georg F Hoffmann; Markus Ries
Journal:  Orphanet J Rare Dis       Date:  2016-05-12       Impact factor: 4.123

2.  Evaluating Hand Function in Clients with Trigger Finger.

Authors:  Danit Langer; Adina Maeir; Michael Michailevich; Shai Luria
Journal:  Occup Ther Int       Date:  2017-01-10       Impact factor: 1.448

3.  Prospective multicentre validation study of a new standardised version of the 400-point hand assessment.

Authors:  Michel Konzelmann; Cyrille Burrus; Colette Gable; François Luthi; Jean Paysant
Journal:  BMC Musculoskelet Disord       Date:  2020-05-20       Impact factor: 2.362

4.  Site-specific Patient-reported Outcome Measures for Hand Conditions: Systematic Review of Development and Psychometric Properties.

Authors:  Justin C R Wormald; Luke Geoghegan; Kyra Sierakowski; Andrew Price; Michele Peters; Abhilash Jain; Jeremy N Rodrigues
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-21

Review 5.  Characteristics and Applications of Technology-Aided Hand Functional Assessment: A Systematic Review.

Authors:  Ciro Mennella; Susanna Alloisio; Antonio Novellino; Federica Viti
Journal:  Sensors (Basel)       Date:  2021-12-28       Impact factor: 3.576

6.  Electromyographic Activity of the Upper Limb in Three Hand Function Tests.

Authors:  Natália Sanches Silva; Pedro Henrique Tavares Queiroz de Almeida; Paulo Vinicius Braga Mendes; Caio Sadao Medeiros Komino; José Marques Novo Jùnior; Daniel Marinho Cezar Da Cruz
Journal:  Hong Kong J Occup Ther       Date:  2017-02-16       Impact factor: 0.917

7.  A team approach to applying the International Classification of Functioning, Disability and Health Rehabilitation set in clinical evaluation.

Authors:  Malan Zhang; Yun Zhang; Yun Xiang; Ziling Lin; Wei Shen; Yingmin Wang; Liyin Wang; Jiani Yu; Tiebin Yan
Journal:  J Rehabil Med       Date:  2021-01-19       Impact factor: 2.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.